Cost Per Treatment: Closed System PRP Kits vs Open Systems

When evaluating the cost per treatment of closed system PRP kits versus open systems, closed systems carry a higher upfront consumable price but reduce total operational cost through faster processing, lower contamination risk, and simplified regulatory compliance. Open systems utilize lower-cost standard laboratory tubes and pipettes, yet they require specialized staff training, longer hands-on preparation time, and stricter environmental controls to maintain sterility.

For medical practice managers, procurement decisions around platelet-rich plasma (PRP) preparation directly impact profit margins, room turnover, and clinical liability. A comprehensive financial analysis must account for both direct supply expenses and the indirect costs of staff labor, quality assurance, and equipment maintenance.

Defining the Operational Models: Closed vs. Open PRP Systems

Before calculating per-procedure economics, practice administrators must understand the functional and regulatory distinctions between the two processing methods.

Closed System PRP Kits

A closed system utilizes a pre-packaged, sterile kit designed to process whole blood without exposing the sample to the ambient environment. Blood is drawn and transferred into a specialized tube or dual-chamber device, centrifuged, and fractionated using mechanical separators, valves, or closed-transfer syringes. Many closed systems hold specific FDA 510(k) clearances for the preparation of autologous platelet-rich plasma, frequently intended for mixing with bone graft materials in orthopedic applications, though clinicians often utilize them off-label across various specialties.

Open System PRP Preparation

An open system—often referred to as a manual or laboratory method—relies on standard blood collection tubes, routine laboratory centrifuges, and manual pipetting or uncapped syringe aspiration to isolate the buffy coat and platelet-poor plasma. Because the tube caps are removed or compromised in an open room environment during extraction, the sample is exposed to ambient air. This manual intervention shifts the burden of sterility and concentration reproducibility entirely onto the technician performing the draw and spin.

True Cost Per Treatment: Beyond the Consumable Price

A common procurement mistake is equating the invoice price of a blood tube with the total cost per treatment. While an open system's raw materials may appear significantly less expensive on a supply ledger, the true cost per treatment encompasses four distinct operational pillars.

1. Direct Consumable and Ancillary Supply Costs

Closed systems are typically sold as all-inclusive kits. A single unit price generally covers the venipuncture butterfly needle, anticoagulant (such as ACD-A), collection syringes, the proprietary concentrating device, and transfer accessories.

In contrast, open systems require itemized purchasing of individual supplies. Practices must procure separate collection tubes, transfer pipettes, needles, syringes, and bulk anticoagulant vials. Furthermore, bulk anticoagulants used across multiple patients introduce tracking requirements and waste due to expiration dates once a vial is punctured.

2. Staff Labor and Room Turnover Time

In a busy clinical setting, medical assistant (MA) or registered nurse (RN) time is a primary cost driver. Closed systems are engineered for workflow efficiency, often requiring a single spin or an automated mechanical separation that takes minutes of active hands-on time.

Open systems frequently require a double-spin protocol and meticulous manual aspiration of the platelet layers. This demands extended, uninterrupted focus from a highly trained staff member. If an open protocol adds fifteen minutes of hands-on technician time per procedure, that labor cost—along with the opportunity cost of an occupied procedure room—quickly erodes the savings gained from cheaper tubes.

3. Training, Reproducibility, and Waste

With an open system, the quality of the final preparation is operator-dependent. If a newly hired technician aspirates too aggressively and mixes the red blood cell layer back into the plasma, the sample may be compromised or require a redraw. Staff turnover creates continuous retraining expenses.

Closed systems standardize the physical separation of blood components. This mechanical barrier reduces operator error, minimizes wasted kits, and allows practice managers to cross-train clinical support staff rapidly.

4. Regulatory Compliance and Liability Exposure

From a risk management perspective, regulatory compliance is a hidden financial factor. Using standard diagnostic blood collection tubes (which are cleared for in vitro diagnostic testing, not in vivo re-injection) to prepare injectable biologics places the practice in a complex regulatory position regarding sterility and pyrogenicity.

Furthermore, because open systems expose the biological sample to room air, strict adherence to infection control standards may require the installation and certification of a laminar flow hood or specialized cleanroom protocols. Closed systems maintain a sterile barrier from venipuncture to syringe loading, mitigating the need for costly facility modifications and reducing the practice's liability profile regarding post-injection infections.

Procurement Checklist: Comparing Closed vs. Open PRP Systems

When auditing your current PRP service line or evaluating new vendor contracts, compare the two models across these operational criteria:

• Upfront Hardware Investment: Closed systems often require a proprietary centrifuge (frequently provided via capital purchase, lease, or consumable volume agreement); open systems utilize standard, swinging-bucket laboratory centrifuges.
• Consumable Unit Cost: Closed kits represent a higher, fixed per-patient cost; open systems have a lower baseline material cost but require multi-item inventory management.
• Technician Hands-On Time: Closed systems require minimal active manipulation; open systems demand dedicated, high-focus manual pipetting.
• Facility Requirements: Closed systems can be processed safely at the point of care in a standard treatment room; open systems ideally require a dedicated clean workspace or laminar flow hood to mitigate airborne contamination.
• Inventory Tracking: Closed kits provide a single lot number for simplified patient charting; open systems require logging multiple lot numbers for tubes, anticoagulants, and transfer devices.
• Clinical Consistency: Closed systems deliver standardized volume and cellular profiles; open systems yield variable results depending on technician skill.

Clinical Perspective: What Physicians Need to Know About Cellular Yield

While practice managers focus on workflow and margins, treating physicians in orthopedics and aesthetics evaluate PRP systems based on cellular composition and clinical efficacy.

Physicians often favor closed systems because the manufacturer provides validated characterization data detailing platelet recovery rates, concentration factors over baseline, and the exact inclusion or exclusion of leukocytes (neutrophils and monocytes) and erythrocytes. Whether a protocol calls for leukocyte-rich PRP for tendon pathology or leukocyte-poor PRP for intra-articular or aesthetic applications, commercial closed systems offer predictable hematological profiles.

Conversely, some clinicians advocate for open or semi-closed laboratory systems because they allow total customization of spin speeds (g-force), spin durations, and plasma volume extraction. However, achieving consistent, therapeutic platelet concentrations in an open system requires in-house hematology analyzers to verify yields regularly—adding another layer of equipment and quality control expense that the practice manager must absorb.

What This Means for Your Practice

Transitioning to or optimizing a regenerative medicine service line requires aligning clinical goals with operational scalability. To determine the most cost-effective PRP workflow for your facility, take the following steps:

1. Conduct a Time-Motion Audit: Track the exact number of minutes your clinical staff spends gathering supplies, processing blood, and cleaning equipment per PRP procedure, then calculate the fully burdened labor cost.
2. Review Regulatory Documentation: Audit the FDA clearance status of the tubes currently in your supply closet. Ensure that no in vitro diagnostic (IVD) laboratory tubes are being utilized for patient re-injection.
3. Standardize Inventory: Consolidate vendors to streamline procurement. Evaluate whether volume tiers or bundled purchasing across devices and biologics can lower your per-kit acquisition cost.
4. Align Pricing with Value: Ensure your patient fee schedule accurately reflects the safety, compliance, and consistency of a commercial closed system.

If your practice is auditing its regenerative supply chain or launching a new service line, our team can help you model the operational economics and evaluate compliant, clinical-grade equipment. Reach out through our contact page to schedule a procurement and workflow consultation with Dallas Regenerative Solutions.